Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Equity Income: 2019-2022

Historic Equity Income for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2022 value amounting to -$8,162.

  • ProQR Therapeutics N.V's Equity Income fell 106.96% to -$8,979 in Q1 2022 from the same period last year, while for Mar 2022 it was -$519,596, marking a year-over-year change of. This contributed to the annual value of -$8,162 for FY2022, which is 96.82% up from last year.
  • ProQR Therapeutics N.V's Equity Income amounted to -$8,162 in FY2022, which was up 96.82% from -$256,797 recorded in FY2021.
  • Over the past 5 years, ProQR Therapeutics N.V's Equity Income peaked at $480,449 during FY2019, and registered a low of -$367,651 during FY2020.
  • In the last 3 years, ProQR Therapeutics N.V's Equity Income had a median value of -$256,797 in 2021 and averaged -$210,870.
  • Per our database at Business Quant, ProQR Therapeutics N.V's Equity Income tumbled by 176.52% in 2020 and then skyrocketed by 96.82% in 2022.
  • Yearly analysis of 4 years shows ProQR Therapeutics N.V's Equity Income stood at $480,449 in 2019, then slumped by 176.52% to -$367,651 in 2020, then surged by 30.15% to -$256,797 in 2021, then skyrocketed by 96.82% to -$8,162 in 2022.